EUVIMEDEUVIMED entdecken
Crossref

Malnutrition in Inflammatory Bowel Diseases. What do we know today?

Christina N. Katsagoni

Kompass Nutrition & Dietetics · 2021

DOI: 10.1159/000516279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kompass Nutrition & Dietetics, 2021. Verfasst von Christina N. Katsagoni. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growth delay with height and weight impairment is a common feature of pediatric inflammatory bowel diseases (PIBD). Up to 2/3 of Crohn Disease patients have impaired weight at diagnosis, and up to 1/3 have impaired height. Ulcerative colitis usually manifests earlier with less impaired growth, though patients can be affected. Ultimately, growth delay, if not corrected, can reduce final adult height. Weight loss, reduced bone mass, and pubertal delay are also concerns associated with growth delay in newly diagnosed PIBD patients. The mechanisms for growth delay in IBD are multifactorial and include reduced nutrient intake, poor absorption, increased fecal losses, as well as direct effects from inflammation and treatment modalities. Management of growth delay requires optimal disease control. Exclusive enteral nutrition (EEN), biologic therapy, and corticosteroids are the primary induction strategies used in PIBD, and both EEN and biologics positively impact growth and bone development. Beyond adequate disease control, growth delay and pubertal delay require a multidisciplinary approach, dependent on diligent monitoring and identification, nutritional rehabilitation, and involvement of endocrinology and psychiatry services as needed. Pitfalls that clinicians may encounter when managing growth delay include refeeding syndrome, obesity (even in the setting of malnutrition), and restrictive diets. Although treatment of PIBD has improved substantially in the last several decades with the era of biologic therapies and EEN, there is still much to be learned about growth delay in PIBD in order to improve outcomes.

Zitieren

APA

Katsagoni, C. N. (2021). Malnutrition in Inflammatory Bowel Diseases. What do we know today?. Kompass Nutrition & Dietetics. https://doi.org/10.1159/000516279

Vancouver

Katsagoni CN. Malnutrition in Inflammatory Bowel Diseases. What do we know today?. Kompass Nutrition & Dietetics. 2021. doi:10.1159/000516279

BibTeX
@article{Katsagoni2021,
  author = {Katsagoni, Christina N.},
  title = {Malnutrition in Inflammatory Bowel Diseases. What do we know today?},
  journal = {Kompass Nutrition & Dietetics},
  year = {2021},
  doi = {10.1159/000516279}
}
Kostenlos starten →